Newsroom
Market News
Both sides of the trade, grades and news round-ups. Click a headline to read it — the arrows walk the list.
Research
- Apple Stock News: Analyst Upgrades to 'Buy' Rating
- AI Hardware Stocks: Navigating the Recent Pullback and Predictions for 2024
- BlackRock (BLK) Surpasses Q1 Earnings Estimates, Assets Hit Record $10.47 Trillion
- Citigroup Beats Q1 Earnings Expectations Amid Booming Investment Banking Fees
- Analyzing the Recent Pullback in Semiconductor Stocks: AMD, Nvidia, and Intel
- Wells Fargo Faces Setback with 1Q NII Miss Despite Strong EPS
- Gold Price Forecast: Surging Towards $3000 Amid Geopolitical Tensions
- Amazon's Investment in Artificial Intelligence and Latin America's E-Commerce Darling
- JPMorgan's Q1 Earnings Report: A Detailed Analysis
- SOLUSD Recent News Highlights
- ADAUSD Recent News Highlights
- XRPUSD Recent News Highlights
- ETHUSD Recent News Highlights
- BTCUSD Recent News Highlights
- Nikola (NASDAQ: NKLA) Stock Plunges as Chairman Pushes for Reverse Stock Split
- Micron (MU) Faces DRAM Supply Impact After Taiwan Earthquake
- Brokers Recommend Investing in Coca-Cola (KO): Here's What You Need to Know
- Johnson & Johnson Faces Dip in First-Quarter Earnings Amid Market Uncertainty
- April Stock News Roundup: Goldman Sachs, Dow Jones, and Big Banks
- Trump Media Stock Plummets as Truth Social Owner Faces Grim Day
- High-Growth Business Services Stocks to Buy Now
- Unlocking Q1 Potential of Bank of America (BAC): Exploring Wall Street Estimates for Key Metrics
- Top 3 Semiconductor Stocks to Watch in April
- United Airlines (UAL) Q1 Earnings Report: What to Expect
- Lovesac (LOVE) Q4 2024 Earnings Report Analysis
- American Eagle Outfitters (AEO) Stock Analysis: Recent Performance and Investor Outlook
- Oil and Natural Gas Forecasts Amid Middle East Tensions
- Rivian Stock Plummets to Record Low Amid Electric-Truck Price Competition
- Biotech Stocks Alpine Immune Sciences and Vertex Pharmaceuticals Drive Nasdaq Surge
- Forever Stocks: 3 Tremendous Growth Picks to Buy and Never Sell
- Paramount Shareholders Express Concerns Over Skydance Media Merger Talks
- Rent the Runway (RENT) Stock Surges 170% on Optimistic 2024 Outlook
- Nike Stock Receives Upgrade from Bank of America, Shares Rise 3.4%
- Tesla (TSLA) Stock News: Analysts' Predictions, Market Performance, and Future Prospects
- Fastenal Stock Falls After Missing Q1 Estimates
- Morgan Stanley Shares Drop on WSJ Probe Report
- Ford Faces Multiple Challenges as it Recalls Vehicles, Faces Investigations, and Cuts Prices
- Boeing Stock News: Key Facts and Analysis
- Constellation Brands (STZ) Soars After Bullish Q4 Earnings Report
- CarMax, Constellation Brands, and Zions Bancorp: A Stock News Roundup
Ask the market a question. Get a calculated answer.
The AI is not a chatbot bolted onto a document store. It calls the same analytics engine that powers every screen on this platform — so what comes back is a number it computed from raw history, with the command that produced it.
86,000+ instruments
Global equities, ETFs, funds, options, FX, commodities, crypto, economics, filings, transcripts and news — one normalised symbol universe with adjusted history.
A real analytics engine
Screening, backtesting, technicals, options analytics, correlations, seasonality and factor models — computed on demand from raw prices, never a stale cache.
It shows its working
Answers arrive with the charts, tables and tool calls behind them, so you can check the number instead of trusting a paraphrase.
Your own documents
Upload filings, decks and research. Ask across them and the answer cites the page it came from.
Agents and workflows
Multi-step research that runs the platform's tools for you — screen, pull the history, compute, compare, then write it up.
MCP, CLI and API
The same command catalogue from Claude, your own agent, a shell or your pipeline. The answer on screen is the answer your job gets at 4am.
You ask
“How does NVDA usually trade through earnings?”
It calls
→ ka.options_expected_move(NVDA)
It answers
NVDA has averaged a 9.2% absolute move on the day after earnings and closed higher 67% of the time. Two in three reactions land between −4.2% and +16.3% — the distribution is skewed right, not symmetric.
Every figure computed live from our own history — not scraped, not summarised.
Or start with